G1691A factor V and G20210A FII mutations, acute ischemic stroke of unknown cause, and patent foramen ovale
Authors:
- Michelangelo SartoriMSMichelangelo Sartori
- Eleonora ContiECEleonora Conti
- Cristina LegnaniCLCristina Legnani
- Gualtiero PalaretiGPGualtiero Palareti
- 1 November 2012
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 130 (5) , 720-724
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Testing for Inherited Thrombophilias in Arterial StrokeStroke, 2010
- Rethinking trial strategies for stroke and patent foramen ovaleCurrent Opinion in Neurology, 2010
- Cryptogenic stroke and patent foramen ovaleCurrent Opinion in Cardiology, 2008
- Prothrombotic Mutations as Risk Factors for Cryptogenic Ischemic Cerebrovascular Events in Young Subjects With Patent Foramen OvaleStroke, 2007
- The Factor V Leiden, Prothrombin Gene 20210GA, Methylenetetrahydrofolate Reductase 677CT and Platelet Glycoprotein IIIa 1565TC Mutations in Patients With Acute Ischemic Stroke and Atrial FibrillationStroke, 2007
- Matched Case-Control Study on Factor V Leiden and the Prothrombin G20210A Mutation in Patients With Ischemic Stroke/Transient Ischemic Attack Up to the Age of 60 YearsStroke, 2005
- Prothrombotic conditions, oral contraceptives, and the risk of ischemic strokeJournal of Thrombosis and Haemostasis, 2005
- Prothrombin G20210A Mutation, but Not Factor V Leiden, Is a Risk Factor in Patients with Persistent Foramen ovale and Otherwise Unexplained Cerebral IschemiaCerebrovascular Diseases, 2003
- Inherited Thrombophilic Disorders in Young Adults With Ischemic Stroke and Patent Foramen OvaleStroke, 2003
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993